KOR

e-Article

The deleterious G15498A mutation in mitochondrial DNA-encoded cytochrome b may remain clinically silent in homoplasmic carriers.
Document Type
Article
Source
European Journal of Human Genetics. Mar2004, Vol. 12 Issue 3, p220-224. 5p.
Subject
*GENETIC mutation
*GENE mapping
*MITOCHONDRIAL DNA
*CYTOCHROME b
*AMINO acids
*GENE expression
Language
ISSN
1018-4813
Abstract
We report on a patient with severe growth retardation and IgF1 deficiency, in which a mitochondrial abnormality was suspected. An isolated mitochondrial respiratory chain complex III deficiency was found in blood lymphocytes and skin fibroblasts. Sequence analysis of the cytochrome b, which is the only mitochondrial DNA-encoded subunit of complex III, revealed a homoplasmic G15498A mutation, resulting in the substitution of a highly conserved amino acid (glycine 251 into an aspartic acid). The mutation was found to be homoplasmic in all tissues examined from the mother and her brother (lymphocytes, fibroblasts, hair roots and buccal cells). Complex III deficiency was also demonstrated in these cells. Nevertheless, the mother and the brother were asymptomatic. This mutation had been considered as a cardiomyopathy-generating mutation in a previously reported case, and its pathogenicity has been demonstrated recently in yeast. However, it seems not to fulfil the classical criteria for pathogenicity of a mitochondrial DNA mutation, especially the heteroplasmic status, and to be clinically silent, albeit present, in nonaffected relatives. We suggest that other factors are contributing to the clinical variability expression of the G15498A mtDNA mutation.European Journal of Human Genetics (2004) 12, 220-224. doi:10.1038/sj.ejhg.5201132 Published online 21 January 2004 [ABSTRACT FROM AUTHOR]